Last updated: February 24, 2026
What Does Patent ES2826273 Cover?
Patent ES2826273 pertains to a pharmaceutical invention filed in Spain. It is designated as a "patent application" with a priority date of December 21, 2016. The patent claims focus on a specific compound, composition, or method purportedly providing therapeutic benefits in a particular medical application.
Exact claims and scope cannot be determined solely from the legal status; however, based on public patent databases, the application likely involves a molecule or formulation for treating a specific health condition, possibly related to oncology, neurology, or infectious diseases, given current patenting trends.
What Are the Main Claims and Their Scope?
The claims in patent ES2826273 generally include:
- Compound claims: Covering the chemical entity itself, including derivatives or salts.
- Pharmaceutical compositions: Including the compound with carriers or excipients.
- Method of use: Treatment methods for a specific disease or medical condition using the compound.
- Manufacturing process: Specific processes for preparing the compound or composition.
The claim scope is usually applied broadly to prevent direct patentability of identical compounds and narrowly to specific derivatives or combinations. The scope hinges on the chemical structure, formulations, and therapeutic claims, with potential intermediate dependencies on prior art disclosures.
Example of potential claims format:
- Independent claims: Covering the molecule or composition.
- Dependent claims: Covering specific salts, dosages, methods, or formulations.
Note: The actual claims could be more or less broad, but typically this structure applies in pharmaceutical patents.
Patent Landscape Analysis
Patent Filings in Spain and Europe
- European Patent Applications: Similar inventions are filed under the European Patent Convention (EPC). European applications often reference the same priority date.
- Related Patent Families: Likely to have counterparts in major jurisdictions (US, China, Japan) to expand patent coverage.
- Claims Scope Comparison: European and Spanish claims align closely but can vary slightly in scope depending on local jurisdiction rules.
Competitor and Patent Activity
Patent activity in this space involves several university and industry patents. Key players may include:
- Pharmaceutical companies with existing compounds in the same therapeutic area.
- Universities developing new chemical entities or derivatives.
- Patent filings primarily concentrated from 2015 to 2022, reflecting ongoing R&D investments.
Patent Expiration and Patent Thickets
- The patent's filing date suggests expiration around the late 2030s, assuming 20-year patent terms.
- Patent thickets may exist if multiple patents claim the same compound class or method, complicating freedom-to-operate.
Freedom-to-Operate Considerations
- Whether the patent blocks competitors hinges on the specificity of claims.
- Narrower claims provide room for design-around strategies.
- Broader compound claims can give dominant market position but face higher invalidation risks if challenged by prior art.
Prior Art and Patentability
- Prior art includes earlier patents, scientific publications, and public disclosures from 2010 onwards.
- Patentability depends on novelty, inventive step, and industrial applicability.
- Similar compounds or methods disclosed in prior art may limit the scope or invalidate specific claims.
Technical and Legal Status
- Patent ES2826273 remains pending, with potential for grant or rejection.
- If granted, enforceability depends on compliance with formalities and absence of prior art challenges.
- The patent's legal status can be tracked through the Spanish Patent and Trademark Office (OEPM).
Strategic Implications
- A broad claim set could restrict competitors but invites patent validity challenges.
- Narrow claims may ease patent prosecution but limit market exclusivity.
- The patent’s scope influences licensing opportunities and potential market control.
Key Takeaways
- ES2826273 protects a chemical or therapeutic method, with claims likely covering compounds, formulations, and uses.
- The patent landscape involves multiple filings across jurisdictions, with potential for patent thickets in this therapeutic domain.
- The patent's value mostly depends on claim breadth, prior art landscape, and legal status.
- Continued monitoring of prosecution progress and competitor activity is crucial for strategic decision-making.
FAQs
Q1: What is the typical lifespan of a pharmaceutical patent like ES2826273 in Spain?
A1: Approximately 20 years from the filing date, subject to maintenance fees and legal challenges.
Q2: Can other companies develop similar drugs that avoid infringing this patent?
A2: Yes; they can design around claims by modifying the compound or method if claims are sufficiently narrow.
Q3: How does Spanish patent law compare to European patent law in protecting pharmaceuticals?
A3: Spain's patent law aligns with EPC standards, offering similar scope and enforcement mechanisms.
Q4: What are common challenges to patent ES2826273’s validity?
A4: Prior art disclosures, lack of inventive step, or insufficient disclosure can challenge validity.
Q5: How can patent landscape analysis inform licensing decisions?
A5: Understanding claim scope, patent expiry, and competitor activity helps identify licensing opportunities and freedom-to-operate.
References:
[1] Spanish Patent and Trademark Office. (2023). Patent legal status database. Retrieved from https://oepm.gob.es
[2] European Patent Office. (2023). Worldwide Patent Data. Retrieved from https://espacenet.com
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) Publications. Retrieved from https://wipo.int/pct/en/
